当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Electroceuticals jolt into the clinic, sparking autoimmune opportunities
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2022-04-19 , DOI: 10.1038/d41573-022-00072-8 Asher Mullard
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2022-04-19 , DOI: 10.1038/d41573-022-00072-8 Asher Mullard
As Galvani Bioelectronics advances its first ‘electroceutical’ candidate for a chronic disease into the clinic, company president Kristoffer Famm discusses the bioelectronic medicines R&D roadmap.
中文翻译:
Electroceuticals 进入诊所,引发自身免疫机会
随着 Galvani Bioelectronics 将其首个针对慢性疾病的“电药”候选药物推向临床,公司总裁 Kristoffer Famm 讨论了生物电子药物研发路线图。
更新日期:2022-04-20
中文翻译:
Electroceuticals 进入诊所,引发自身免疫机会
随着 Galvani Bioelectronics 将其首个针对慢性疾病的“电药”候选药物推向临床,公司总裁 Kristoffer Famm 讨论了生物电子药物研发路线图。